BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8550789)

  • 21. Alterations of RET oncogene in human adrenal tumors.
    Lin SR; Yang YC; Tsai JH; Hsu CH
    Jpn J Cancer Res; 1998 Jun; 89(6):634-40. PubMed ID: 9703361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germ line mutation in the RET proto-oncogene associated with familial multiple endocrine neoplasia type 2B: a case report.
    Ishida O; Zeki K; Morimoto I; Yamamoto S; Fujihira T; Eto S
    Jpn J Clin Oncol; 1995 Jun; 25(3):104-8. PubMed ID: 7596047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple endocrine neoplasia: the paradigm of the arrival of molecular biology in clinical practice.
    Gonçalves LM
    Rev Port Cardiol; 2000 Jan; 19(1):33-8. PubMed ID: 10731789
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
    Crossey PA; Eng C; Ginalska-Malinowska M; Lennard TW; Wheeler DC; Ponder BA; Maher ER
    J Med Genet; 1995 Nov; 32(11):885-6. PubMed ID: 8592333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas.
    van der Harst E; de Krijger RR; Bruining HA; Lamberts SW; Bonjer HJ; Dinjes WN; Proye C; Koper JW; Bosman FT; Roth J; Heitz PU; Komminoth P
    Int J Cancer; 1998 Oct; 79(5):537-40. PubMed ID: 9761126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.
    Komminoth P; Kunz E; Hiort O; Schröder S; Matias-Guiu X; Christiansen G; Roth J; Heitz PU
    Am J Pathol; 1994 Oct; 145(4):922-9. PubMed ID: 7943181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.
    Jimenez C; Habra MA; Huang SC; El-Naggar A; Shapiro SE; Evans DB; Cote G; Gagel RF
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4142-5. PubMed ID: 15292360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel Val648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin-producing pheochromocytoma.
    Nunes AB; Ezabella MC; Pereira AC; Krieger JE; Toledo SP
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5658-61. PubMed ID: 12466368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G; Stanojević B; Palmar I; Dimitrijević B
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sporadic type composite pheochromocytoma with neuroblastoma: clinicomorphologic, DNA content and ret gene analysis.
    Candanedo-González FA; Alvarado-Cabrero I; Gamboa-Domínguez A; Cérbulo-Vázquez A; López-Romero R; Bornstein-Quevedo L; Salcedo-Vargas M
    Endocr Pathol; 2001; 12(3):343-50. PubMed ID: 11740055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Consequences of clinical genetic analysis of RET proto-oncogene].
    Włoch J; Wygoda Z; Wiench M; Gubała E; Kula D; Oczko M; Lange D; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():406-14. PubMed ID: 12182057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
    Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Huang SC; Koch CA; Vortmeyer AO; Pack SD; Lichtenauer UD; Mannan P; Lubensky IA; Chrousos GP; Gagel RF; Pacak K; Zhuang Z
    Cancer Res; 2000 Nov; 60(22):6223-6. PubMed ID: 11103773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of Ret activation by a mutation at aspartic acid 631 identified in sporadic pheochromocytoma.
    Asai N; Iwashita T; Murakami H; Takanari H; Ohmori K; Ichihara M; Takahashi M
    Biochem Biophys Res Commun; 1999 Feb; 255(3):587-90. PubMed ID: 10049754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A.
    Quadro L; Panariello L; Salvatore D; Carlomagno F; Del Prete M; Nunziata V; Colantuoni V; Di Giovanni G; Brandi ML; Mannelli M
    J Clin Endocrinol Metab; 1994 Aug; 79(2):590-4. PubMed ID: 7913936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?
    Gimm O; Niederle BE; Weber T; Bockhorn M; Ukkat J; Brauckhoff M; Thanh PN; Frilling A; Klar E; Niederle B; Dralle H
    Surgery; 2002 Dec; 132(6):952-9; discussion 959. PubMed ID: 12490841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B.
    Smith-Hicks CL; Sizer KC; Powers JF; Tischler AS; Costantini F
    EMBO J; 2000 Feb; 19(4):612-22. PubMed ID: 10675330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.